EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2

Oswaldo Antonio Caguana-Vélez, Karys Khilzi, Lucilla Piccari, Juan Jose Rodríguez-Sevilla, Diana Badenes-Bonet, Jose Gonzalez-Garcia, Roberto Chalela, Mariela Arita, Anna Rodó-Pin, Anna Herranz, Mireia Admetlló, Judit Villar-Garcia und 5 weitere

Respiration · 2024 · 103 (2) · 79-87

DOI: 10.1159/000536064 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Respiration, online erschienen am 07.02.2024. Verfasst von Oswaldo Antonio Caguana-Vélez und 16 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain, oswaldoantonio.caguana01@estudiant.upf.edu. Hauptthemen laut MEDLINE: COVID-19, Hypertension, Pulmonary, Pulmonary Embolism, Thromboembolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic thromboembolic pulmonary disease (CTEPD) consists of persistent pulmonary vascular obstruction on imaging and involves long-term functional limitations, with or without chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to evaluate the incidence and risk factors of both persistent pulmonary vascular defects and CTEPH after hospitalization in patients with COVID-19 and PE during a 2-year follow-up.

Methods

A prospective observational study was carried out in a tertiary hospital center. Patients were hospitalized between March 2020 and December 2021 with a diagnosis of PE during SARS-CoV-2 infection. Patients received anticoagulant treatment for at least 3 months and were followed up for 2 years. Between the third and fourth months after discharge, all patients were evaluated for the presence of residual thrombotic defects by CTPA and/or perfusion pulmonary scintigraphy. Clinical findings, lung function tests with DLCO, exercise capacity, and echocardiograms were also assessed.

Results

Of the 133 patients included, 18% had persistent thrombotic defects on lung imaging at follow-up. The incidence of CTEPD was 0.75% at 2 years of follow-up. Patients with persistent defects were significantly older, had a higher prevalence of systemic arterial hypertension, higher D-dimer and NT-proBNP levels, and more severe PE at diagnosis. Furthermore, there was a higher prevalence of right ventricular dysfunction on echocardiogram at diagnosis of PE (25.0% vs. 2.7%, p = 0.006). This was the only variable independently related to persistent defects in multivariate analyses (OR: 8.13 [95% CI: 1.82–36.32], p = 0.006).

Conclusion

The persistence of thrombotic defects after PE is a common finding after SARS-CoV-2 infection, affecting 18% of the population. However, the incidence of CTEPH appears to be lower (0.75%) in COVID-19-related PE compared to that previously observed in PE unrelated to COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hypertension, PulmonaryPulmonary EmbolismThromboembolismHumansChronic DiseaseLungSARS-CoV-2Prospective Studies

Stichwörter der Autor:innen

COVID-19Chronic thromboembolic diseaseChronic thromboembolic pulmonary hypertensionPulmonary embolismSARS-CoV-2

Autor:innen und Institutionen

  • Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain, oswaldoantonio.caguana01@estudiant.upf.edu.
  • Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain, oswaldoantonio.caguana01@estudiant.upf.edu.
  • IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain, oswaldoantonio.caguana01@estudiant.upf.edu.
  • Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain.
  • IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Hematology Department, Hospital del Mar, Barcelona, Spain.

Zitieren

APA

Caguana-Vélez, O. A., Khilzi, K., Piccari, L., Rodríguez-Sevilla, J. J., Badenes-Bonet, D., Gonzalez-Garcia, J., Chalela, R., Arita, M., Rodó-Pin, A., Herranz, A., Admetlló, M., Villar-Garcia, J., Molina, L., Zuccarino, F., Gea, J., Balcells, E., & Rodríguez-Chiaradia, D. A. (2024). Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration, 103(2), 79-87. https://doi.org/10.1159/000536064

Vancouver

Caguana-Vélez OA, Khilzi K, Piccari L, Rodríguez-Sevilla JJ, Badenes-Bonet D, Gonzalez-Garcia J, et al. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration. 2024;103(2):79-87. doi:10.1159/000536064

BibTeX
@article{CaguanaVlez2024,
  author = {Caguana-Vélez, Oswaldo Antonio and Khilzi, Karys and Piccari, Lucilla and Rodríguez-Sevilla, Juan Jose and Badenes-Bonet, Diana and Gonzalez-Garcia, Jose and Chalela, Roberto and Arita, Mariela and Rodó-Pin, Anna and Herranz, Anna and Admetlló, Mireia and Villar-Garcia, Judit and Molina, Lluis and Zuccarino, Flavio and Gea, Joaquin and Balcells, Eva and Rodríguez-Chiaradia, Diego A},
  title = {Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2},
  journal = {Respiration},
  year = {2024},
  volume = {103},
  number = {2},
  pages = {79--87},
  doi = {10.1159/000536064}
}
Kostenlos starten →